Pfizer reported more than $50 bn in revenue last year. Its Covid-19 vaccine is expected to generate about $14.6 bn in revenue 2021—some of which will be paid out to its German biotech partner BioNTech = important but will not change the firms business.
wsj.com/graphics/covid… https://t.co/0veS5QvbiH
RT @BJMbraun: How to be an effective political economist: Laser focus on the neuralgic points of the state-market nexus, follow
May 18, 2023
RT @BJMbraun: How to be an effective political economist: Laser focus on the neuralgic points of the state-market nexus, follow the money,…